Shandong Lukang Pharmaceutical Co.,Ltd.

SHSE:600789 Stock Report

Market Cap: CN¥7.6b

Shandong Lukang PharmaceuticalLtd Management

Management criteria checks 3/4

Shandong Lukang PharmaceuticalLtd's CEO is Kun Dong, appointed in May 2021, has a tenure of 3.5 years. directly owns 0.034% of the company’s shares, worth CN¥2.56M. The average tenure of the management team and the board of directors is 8.7 years and 5.5 years respectively.

Key information

Kun Dong

Chief executive officer

CN¥1.1m

Total compensation

CEO salary percentagen/a
CEO tenure3.5yrs
CEO ownership0.03%
Management average tenure8.7yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

A Piece Of The Puzzle Missing From Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) 26% Share Price Climb

Nov 11
A Piece Of The Puzzle Missing From Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) 26% Share Price Climb

We Think You Should Be Aware Of Some Concerning Factors In Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Earnings

Nov 05
We Think You Should Be Aware Of Some Concerning Factors In Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Earnings

Does Shandong Lukang PharmaceuticalLtd (SHSE:600789) Have A Healthy Balance Sheet?

Sep 26
Does Shandong Lukang PharmaceuticalLtd (SHSE:600789) Have A Healthy Balance Sheet?

Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) Price Is Out Of Tune With Earnings

Aug 21
Shandong Lukang Pharmaceutical Co.,Ltd.'s (SHSE:600789) Price Is Out Of Tune With Earnings

Is Shandong Lukang PharmaceuticalLtd (SHSE:600789) A Risky Investment?

Jun 03
Is Shandong Lukang PharmaceuticalLtd (SHSE:600789) A Risky Investment?

Shandong Lukang Pharmaceutical Co.,Ltd. (SHSE:600789) Surges 26% Yet Its Low P/E Is No Reason For Excitement

May 06
Shandong Lukang Pharmaceutical Co.,Ltd. (SHSE:600789) Surges 26% Yet Its Low P/E Is No Reason For Excitement

Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Solid Profits Have Weak Fundamentals

Apr 03
Shandong Lukang PharmaceuticalLtd's (SHSE:600789) Solid Profits Have Weak Fundamentals

CEO

Kun Dong (54 yo)

3.5yrs

Tenure

CN¥1,130,400

Compensation

Mr. Kun Dong is General Manager and Director at Shandong Lukang Pharmaceutical Co.,Ltd since May 19, 2021. He was Deputy General Manager of Shandong Lukang Pharmaceutical Co.,Ltd.


Leadership Team

NamePositionTenureCompensationOwnership
Kun Dong
GM & Director3.5yrsCN¥1.13m0.034%
CN¥ 2.6m
Li Li
CFO & Director8.7yrsCN¥888.10k0.043%
CN¥ 3.2m
Lixin Tian
Secretary of the Board of Directors23.8yrsCN¥597.90k0.031%
CN¥ 2.4m
Haifeng Cao
Deputy General Managerno dataCN¥902.60k0.015%
CN¥ 1.1m
Defeng He
Deputy General Managerno dataCN¥889.40k0.015%
CN¥ 1.1m

8.7yrs

Average Tenure

54yo

Average Age

Experienced Management: 600789's management team is seasoned and experienced (8.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kun Dong
GM & Director3.5yrsCN¥1.13m0.034%
CN¥ 2.6m
Li Li
CFO & Director3.5yrsCN¥888.10k0.043%
CN¥ 3.2m
Jie Zhang
Directorno dataCN¥825.60k0.034%
CN¥ 2.6m
Cheng Yong Zhang
Director2.5yrsno datano data
Peng Xin
Chairman6.5yrsCN¥1.37m0.064%
CN¥ 4.9m
Ke Chun Cong
Director15.6yrsno datano data
Chengtong Liu
Vice Chairman of the Supervisory Board10.4yrsno datano data
Shuai Yang
Employee Representative Member of Supervisory Board11.6yrsno datano data
Haodong Qi
Independent Director3.5yrsCN¥100.00kno data
Zhi Yong Yang
Chairman of the Supervisory Board6.5yrsno datano data
Zi Xin Deng
Independent Director3.5yrsCN¥100.00kno data
Tao Zhang
Employee Representative Supervisor5.5yrsno datano data

5.5yrs

Average Tenure

52.5yo

Average Age

Experienced Board: 600789's board of directors are considered experienced (5.5 years average tenure).